Multiple Choice Questions in Healthcare Quality 11-20
MCQs in Healthcare Quality 11-20 Will help you pass CPHQ
MCQs in Healthcare Quality 11-20 Will help you pass CPHQ
Tofacitinib inhibits Janus kinase (JAK) enzymes, JAKs activate signal transducers and activators of transcription (STATs), which regulate gene expression and intracellular activity.
The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with Xeljanz, Xeljanz XR (tofacitinib) compared with tumor necrosis factor inhibitors. The safety trial also investigated other potential risks, including blood clots in the lungs and death, but those results are not yet available.
Jump to Questions Quality is becoming more important throughout the [...]